Search Results

Site Search

The Bullet Catch and Other Deadly Illusions! - Insights

In this episode of “Lab Medicine Rounds,” host Justin Kreuter, M.D., speaks with Reade Quinton, M.D., assistant professor of laboratory medicine and

AI in Education - Insights

In this episode of Lab Medicine Rounds, Justin Kreuter, M.D., speaks with career educator, Elissa Hall, Ed.D., on the integration and impact of artificial intelligence in graduate medical education, exploring strategies for teaching AI, the...

Attending Medical Conferences & AABB Debrief - Insights

In this episode of Lab Medicine Rounds, Justin Kreuter, M.D., interviews John Sherbeck, M.D., Laboratory Medical Director of Trinity Health IHA Medical Group, about how to plan your time at medical conferences and briefly discusses this...

April new tests - Insights

In April 2021, Mayo Clinic Laboratories announced two new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

New tests launched in February - Insights

In February 2021, Mayo Clinic Laboratories announced three new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

New tests launched in August - Insights

In August 2021, Mayo Clinic Laboratories announced three new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

Dr. Matt Binnicker sheds light on new Arcturus COVID-19 variant - Insights

Matthew Binnicker, Ph.D., director of Mayo Clinic’s Clinical Virology Laboratory, provides insight on the newest COVID-19 subvariant – XBB.1.16, also known as “Arcturus.”

Study finds safe, effective use of neutralizing monoclonal antibodies in COVID-19 treatment - Insights

A team of researchers has confirmed that neutralizing monoclonal antibody (nMAb) therapies are associated with reduced risk of adverse outcomes of COVID-19 in high-risk populations. The cohort study, published in JAMA, included more than...

TPMT Testing in Treatment of Inflammatory Bowel Disease [Test in Focus] - Insights

Detection of individuals with low thiopurine methyltransferase (TPMT) activity who are at risk for excessive myelosuppression or severe hematopoietic toxicity when taking thiopurine drugs.

Week in Review: March 17 - Insights

Today's Highlights Include: Rochester public schools receives grant to support youth mental health, and FDA releases new regs intended to help detect breast cancer sooner.